1. ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk;M. Authors/Task Force, E.S.C.C.f.P. Guidelines, E.S.C.N.C. Societies;Atherosclerosis,2019
2. Targeting vascular (endothelial) dysfunction;Daiber;Br. J. Pharmacol.,2017
3. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force;Corretti;J. Am. Coll. Cardiol.,2002
4. Flow-mediated dilation and cardiovascular risk prediction: a systematic review with meta-analysis;Ras;Int. J. Cardiol.,2013
5. Vascular hypercontractility and endothelial dysfunction before development of atherosclerosis in moderate dyslipidemia: role for nitric oxide and interleukin-6;Cavieres;Am J Cardiovasc Dis,2014